| |
| |
Preface | |
| |
| |
Acknowledgments | |
| |
| |
About the Author | |
| |
| |
Foreword | |
| |
| |
| |
Terms of Trade: The Flow of Funds Through the Health Care System | |
| |
| |
| |
What is Economics? | |
| |
| |
| |
The Flow of Funds | |
| |
| |
| |
Quality | |
| |
| |
| |
Public or Private Choices | |
| |
| |
| |
Research | |
| |
| |
| |
Time | |
| |
| |
| |
Economic Principles as Conceptual Tools | |
| |
| |
| |
Health Principles | |
| |
| |
| |
Health and The Economy | |
| |
| |
| |
Demand and Supply | |
| |
| |
| |
Need Versus Demand | |
| |
| |
| |
The Demand Curve | |
| |
| |
| |
Marginal Revenue | |
| |
| |
| |
Is Money the Only Price? | |
| |
| |
| |
Supply: Inputs and Production Functions | |
| |
| |
| |
Markets | |
| |
| |
| |
The Production of Health | |
| |
| |
| |
Efficiency | |
| |
| |
| |
Cost-Benefit and Cost-Effectiveness Analysis | |
| |
| |
| |
Cost-Benefit Analysis is about Making Choices | |
| |
| |
| |
Maximization: Finding the Optimum | |
| |
| |
| |
Measuring Benefits | |
| |
| |
| |
Measuring Costs | |
| |
| |
| |
Evidence-Based Medicine | |
| |
| |
| |
The Value of Life | |
| |
| |
| |
Quality-Adjusted Life Years (QALYs) | |
| |
| |
| |
Perspectives: Patient, Payer, Government, Provider, Society | |
| |
| |
| |
Health Insurance: Financing Medical Care | |
| |
| |
| |
Methods for Covering Risks | |
| |
| |
| |
Insurance: Third-Party Payment | |
| |
| |
| |
Risk Aversion | |
| |
| |
| |
Adverse Selection | |
| |
| |
| |
Moral Hazard | |
| |
| |
| |
Tax Benefits | |
| |
| |
| |
Effects of Health Insurance on Labor Markets | |
| |
| |
| |
History of Health Insurance | |
| |
| |
| |
Financing Health Care: Insurance as a Funding Mechanism | |
| |
| |
| |
Insurance Contracts and Managed Care | |
| |
| |
| |
Types of Insurance Plans | |
| |
| |
| |
HSA's, Medical Savings Accounts and "Consumer-Driven Health Plans." | |
| |
| |
| |
A Range of Risk Bearing: Fixed Premiums, Administered Services Only, and Self-Insurance | |
| |
| |
| |
Managed Care Plans | |
| |
| |
| |
The Range of Managed Care Plans | |
| |
| |
| |
Is Managed Care The Solution to Rising Costs? | |
| |
| |
| |
Managed Competition: The Enthoven Plan | |
| |
| |
| |
Incentives-To Patients, To Payers, and To Providers | |
| |
| |
| |
Physicians | |
| |
| |
| |
Financing Physician Services: Revenues | |
| |
| |
| |
Physician Incomes | |
| |
| |
| |
Physician Financing: Expenses | |
| |
| |
| |
The Transaction Between Doctor And Patient | |
| |
| |
| |
Uncertainty | |
| |
| |
| |
Licensure: Quality or Profits? | |
| |
| |
| |
Medical Education, Organization, and Business Practices | |
| |
| |
| |
Medical Education | |
| |
| |
| |
The Origins of Licensure and Linkage to Medical Education | |
| |
| |
| |
Adjusting Physician Supply | |
| |
| |
| |
Group Practice: How Organization and Technology affect Transactions | |
| |
| |
| |
Kickbacks, Self-Dealing, and Side Payments | |
| |
| |
| |
Price Discrimination | |
| |
| |
| |
Practice Variations | |
| |
| |
| |
Insurance, Price Competition, and The Structure of Medical Markets | |
| |
| |
| |
Hospitals | |
| |
| |
| |
From Charitable Institutions to Corporate Chains: Development of the Modern Hospital | |
| |
| |
| |
Hospital Financing: Revenues | |
| |
| |
| |
Hospital Financing: Expenses | |
| |
| |
| |
Financial Management and Cost Shifting | |
| |
| |
| |
How do Hospitals Compete? | |
| |
| |
| |
Organization: Who Controls The Hospital and for What Ends? | |
| |
| |
| |
Management and Regulation of Hospital Costs | |
| |
| |
| |
Why do some Hospitals Cost more than Others? | |
| |
| |
| |
How Management Controls Costs | |
| |
| |
| |
Conflict Between Economic Theory and Accounting Measures of Per Unit Cost | |
| |
| |
| |
Economies of Scale | |
| |
| |
| |
Quality and Cost | |
| |
| |
| |
Controlling Hospital Costs Through Regulation | |
| |
| |
| |
Long-Term Care | |
| |
| |
| |
Development of The Long-Term Care Market | |
| |
| |
| |
Defining Ltc: Types of Care | |
| |
| |
| |
Medicaid: Nursing Homes as A Two-Part Market | |
| |
| |
| |
Certificate of Need: Whose Needs? | |
| |
| |
| |
Case-Mix Reimbursement | |
| |
| |
| |
Substitution | |
| |
| |
| |
Financial Reimbursement Cycles | |
| |
| |
| |
Continuing Care Retirement Communities and The Wealthy Elderly | |
| |
| |
| |
The Effects of aging on Cost and Utilization | |
| |
| |
| |
Pharmaceuticals | |
| |
| |
| |
Pharmaceutical Revenues: Sourceso Of FI | |